Skip to main content

Table 1 Demographics, clinicopathologic characteristics, and therapeutic information of the enrolled UTUC patients

From: Prognostic nomogram for overall survival in upper urinary tract urothelial carcinoma (UTUC) patients treated with chemotherapy: a SEER-based retrospective cohort study

Characteristics

Received chemotherapy

Unreceived chemotherapy

Total

P value

(N = 4441)

(N = 1257)

(N = 5698)

Age (years)

   

< 0.001*

 Mean (SD)

72.1 (11.0)

67.2 (10.4)

71.1 (11.1)

 

Sex

   

0.076

 Female

1943 (43.8%)

514 (40.9%)

2457 (43.1%)

 

 Male

2498 (56.2%)

743 (59.1%)

3241 (56.9%)

 

Race

   

< 0.001*

 White

3887 (87.5%)

1051 (83.6%)

4938 (86.7%)

 

 Black

185 (4.2%)

53 (4.2%)

238 (4.2%)

 

 Other

369 (8.3%)

153 (12.2%)

522 (9.2%)

 

Marital status

   

< 0.001*

 Married

2658 (59.9%)

890 (70.8%)

3548 (62.3%)

 

 Divorced/widowed/Separated

1363 (30.7%)

248 (19.7%)

1611 (28.3%)

 

 Unmarried/Single

420 (9.5%)

119 (9.5%)

539 (9.5%)

 

Primary Site

   

0.358

 Renal Pelvis

2933 (66.0%)

812 (64.6%)

3745 (65.7%)

 

 Ureter

1508 (34.0%)

445 (35.4%)

1953 (34.3%)

 

Grade

   

< 0.001*

 Grade I

246 (5.5%)

21 (1.7%)

267 (4.7%)

 

 Grade II

801 (18.0%)

77 (6.1%)

878 (15.4%)

 

 Grade III

1253 (28.2%)

404 (32.1%)

1657 (29.1%)

 

 Grade IV

2141 (48.2%)

755 (60.1%)

2896 (50.8%)

 

T Stage

   

< 0.001*

 T1

1642 (37.0%)

177 (14.1%)

1819 (31.9%)

 

 T2

881 (19.8%)

132 (10.5%)

1013 (17.8%)

 

 T3

1598 (36.0%)

694 (55.2%)

2292 (40.2%)

 

 T4

320 (7.2%)

254 (20.2%)

574 (10.1%)

 

N Stage

   

< 0.001*

 N0

4123 (92.8%)

779 (62.0%)

4902 (86.0%)

 

 N1

186 (4.2%)

262 (20.8%)

448 (7.9%)

 

 N2

132 (3.0%)

216 (17.2%)

348 (6.1%)

 

M Stage

   

< 0.001*

 M0

4286 (96.5%)

1024 (81.5%)

5310 (93.2%)

 

 M1

155 (3.5%)

233 (18.5%)

388 (6.8%)

 

Radiation

   

1.000

 No/Unknown

19 (0.4%)

6 (0.5%)

25 (0.4%)

 

 Yes

4422 (99.6%)

1251 (99.5%)

5673 (99.6%)

 

Surgical methods of the primary site

   

< 0.001*

 No

26 (0.6%)

124 (9.9%)

150 (2.6%)

 

 Local Mass resection/destruction

163 (3.7%)

49 (3.9%)

212 (3.7%)

 

 Partial nephrectomy/ureterectomy

472 (10.6%)

114 (9.1%)

586 (10.3%)

 

 Radical nephroureterectomy

2600 (58.5%)

586 (46.6%)

3186 (55.9%)

 

 Radical nephrectomy

1014 (22.8%)

324 (25.8%)

1338 (23.5%)

 

 Multivisceral resection

166 (3.7%)

60 (4.8%)

226 (4.0%)

 

Surgery of Lymph nodes (LNs)

   

< 0.001*

 No

3413 (76.9%)

716 (57.0%)

4129 (72.5%)

 

 1 to 3 regional LNs removed

610 (13.7%)

268 (21.3%)

878 (15.4%)

 

 4 or more regional LNs removed

418 (9.4%)

273 (21.7%)

691 (12.1%)

 
  1. *P < 0.05 indicating statistical significance